Loading ...
Sorry, an error occurred while loading the content.

Re: [psychiatry-research] Paper: The Cost of Pushing Pills - A New Estimate of Pharmaceutical Promotion Expenditures in the United States

Expand Messages
  • Jim Goodwin
    How can we be so clueless and Big Pharma so astute? But of course the medical effect of their pills can only go so far. But when you add a big glitzy ad
    Message 1 of 3 , Jan 5, 2008
    • 0 Attachment
      How can we be so clueless and Big Pharma so astute?

      But of course the medical effect of their pills can only go so far. But when you add a big glitzy ad campaign, you add the additional and significant benefit of the placebo effect to their humdrum drug and voilà; a better effect, a better mousetrap resulting in a lot better $$$$ return; what capitalism is all about.

      Placebo effect-right in front of our noses and "scientists" belittle it. The Big Pharma accountants love it!

      Jim G.

      Robert Karl Stonjek <stonjek@...> wrote:
      The Policy Forum allows health policy makers around the world to discuss challenges and opportunities for improving health care in their societies.

      The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States Marc-André Gagnon*, Joel Lexchin

      Funding: The authors received no specific funding for this article.
      Competing Interests: The authors have declared that no competing interests exist.
      Citation: Gagnon MA, Lexchin J (2008) The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States. PLoS Med 5(1): e1 doi:10.1371/journal.pmed.0050001
      Published: January 3, 2008 Copyright: © 2008 Gagnon and Lexchin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
      Abbreviations: AWP, average wholesale price; PhRMA, Pharmaceutical Research and Manufacturers of America; R&D, research and development
      Marc-André Gagnon is with the Département de Sociologie,Université du Québec à Montréal, Montreal, Quebec, Canada. Joel Lexchin is with the School of Health Policy and Management, York University, Toronto, Ontario, Canada
      * To whom correspondence should be addressed. E-mail: ma.gagnon@...

      <Snip>
    Your message has been successfully submitted and would be delivered to recipients shortly.